Entecavir

CAS No. 142217-69-4

Entecavir ( —— )

Catalog No. M11771 CAS No. 142217-69-4

Entecavir(BMS200475; SQ34676) is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process; oral antiHBV drug.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 71 In Stock
25MG 106 In Stock
50MG 152 In Stock
100MG 267 In Stock
200MG 410 In Stock
500MG 662 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Entecavir
  • Note
    Research use only, not for human use.
  • Brief Description
    Entecavir(BMS200475; SQ34676) is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process; oral antiHBV drug.
  • Description
    Entecavir(BMS200475; SQ34676) is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process; oral antiHBV drug.
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    HBV
  • Recptor
    HBV( HepG2 cell)
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    142217-69-4
  • Formula Weight
    277.28
  • Molecular Formula
    C12H15N5O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Levine S, et al. Antimicrob Agents ChemOthers, 2002, 46(8), 2525-2532.
molnova catalog
related products
  • Inarigivir ammonium

    Inarigivir ammonium is a dinucleotide antiviral compound that significantly reduces HBV DNA in transgenic mice expressing hepatitis B virus. Inarigivir is an agonist of retinoic acid-inducible gene-I (RIG-I) that activates intracellular innate immunity.

  • Pradefovir

    Pradefovir is a reverse transcriptase inhibitor potentially for treatment of chronic HBV infection.

  • Besifovir(b)

    Besifovir a parent drug converted by LB80380 further metabolizes to its active form LB80317. LB80380 is potent antiviral agent against hepatitis B virus (HBV).